Blog
RSS FeedPosted by Michael Wonder on 15 Jul 2022
PBAC Public Summary Documents (first time rejections and deferrals) – March 2022 meeting
15 July 2022 - The Public Summary Documents (first time rejections and deferrals) from the March 2022 PBAC meeting are now ...
Posted by Michael Wonder on 11 Jul 2022
Drug Utilisation SubCommittee outcome statement
8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...
Posted by Michael Wonder on 01 Jul 2022
Public Summary Documents – March 2022 PBAC meeting
1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...
Posted by Michael Wonder on 14 Apr 2022
Public summary documents – December 2021 PBAC meeting (first time decisions not to recommend, deferrals and other matters)
14 April 2022 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the December ...
Posted by Michael Wonder on 09 Apr 2022
Life Saving Drugs Program – medicines reviews recommendations
7 April 2022 - This document outlines 51 recommendations from the Life Saving Drugs Expert Panel review. ...
Posted by Michael Wonder on 01 Apr 2022
Public Summary Documents – December 2021 PBAC meeting
1 April 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2021 PBAC ...
Posted by Michael Wonder on 25 Mar 2022
DUSC utilisation analysis public release documents
25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...
Posted by Michael Wonder on 18 Mar 2022
Public summary documents – November 2021 PBAC meeting (first time rejections and deferrals)
18 March 2022 - The Public Summary Documents (first time rejections and deferrals) from the November 2021 PBAC meeting are now ...
Posted by Michael Wonder on 04 Mar 2022
Public summary documents – November 2021 PBAC meeting
4 March 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2021 PBAC ...
Posted by Michael Wonder on 30 Jan 2022
How are child specific utility instruments used in decision making in Australia? A review of Pharmaceutical Benefits Advisory Committee public summary documents.
28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...
Posted by Michael Wonder on 14 Jan 2022
PBAC Public Summary Documents – September 2021 meeting (first time rejections and deferrals)
14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...
Posted by Michael Wonder on 26 Dec 2021
Public Summary Documents – September 2021 PBAC meeting
24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...
Posted by Michael Wonder on 26 Dec 2021
PBS expenditure and prescriptions report 2020-21
24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...
Posted by Michael Wonder on 26 Dec 2021
Report on the collection of under co-payment data 2020-21
24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...
Posted by Michael Wonder on 25 Nov 2021
Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...